MedTrace Logo

Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?

NCT06420115 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 580

Last updated 2025-03-25

No results posted yet for this study

Summary

Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer

Conditions

  • Prostate Cancer Diagnosis

Interventions

DEVICE

different needle size for prostate biopsy

MRI Fusion Transperineal Prostate Biopsy

Sponsors & Collaborators

  • University Hospital Padova

    lead OTHER

Principal Investigators

  • Fabio Zattoni, MD, PhD · Department of Surgery, Oncology and Gastroenterology, Urology Clinic, University of Padua, Padova,

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-12-01
Completion
2026-05-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06420115 on ClinicalTrials.gov